Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 06, 2017 09:12 ET | Source: Immune Therapeutics, Inc.

Immune Therapeutics, Inc. Announces Exclusive Agreement for Sale of Lodonal in Kenya Valued at Over $31 Million

ORLANDO, Fla., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing Lodonal™, its patented,...
January 26, 2017 10:16 ET | Source: Investor Relations Partners

Immune Therapeutics Retains Investor Relations Partners to Support Company’s Strategic IR Program as it Prepares for Commercialziation

ORLANDO, Fla., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Investor Relations Partners (IRP), one of the fastest growing investor and public relations firms in the nation, today announced that Immune...
August 02, 2016 09:07 ET | Source: Investor Relations Partners

Investor Relations Partners Places Two Major Media Stories for Newest Clients; IRP Discusses Keys to Its Extraordinary Client Success

LOS ANGELES, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Investor Relations Partners, Inc. (“IRP”), a full-service investor relations firm serving a global client base, today reported its media relations...